PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FTXH vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FTXH and XLV is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

FTXH vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-0.24%
-5.48%
FTXH
XLV

Key characteristics

Sharpe Ratio

FTXH:

0.39

XLV:

0.35

Sortino Ratio

FTXH:

0.61

XLV:

0.54

Omega Ratio

FTXH:

1.08

XLV:

1.07

Calmar Ratio

FTXH:

0.57

XLV:

0.31

Martin Ratio

FTXH:

1.31

XLV:

1.06

Ulcer Index

FTXH:

3.81%

XLV:

3.57%

Daily Std Dev

FTXH:

12.91%

XLV:

10.92%

Max Drawdown

FTXH:

-32.11%

XLV:

-39.17%

Current Drawdown

FTXH:

-8.71%

XLV:

-12.34%

Returns By Period

In the year-to-date period, FTXH achieves a 2.45% return, which is significantly higher than XLV's 1.83% return.


FTXH

YTD

2.45%

1M

-0.51%

6M

0.63%

1Y

3.67%

5Y*

3.97%

10Y*

N/A

XLV

YTD

1.83%

1M

-3.25%

6M

-5.17%

1Y

3.11%

5Y*

7.75%

10Y*

8.63%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FTXH vs. XLV - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than XLV's 0.12% expense ratio.


FTXH
First Trust Nasdaq Pharmaceuticals ETF
Expense ratio chart for FTXH: current value at 0.60% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.60%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

FTXH vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FTXH, currently valued at 0.39, compared to the broader market0.002.004.000.390.35
The chart of Sortino ratio for FTXH, currently valued at 0.61, compared to the broader market-2.000.002.004.006.008.0010.000.610.54
The chart of Omega ratio for FTXH, currently valued at 1.08, compared to the broader market0.501.001.502.002.503.001.081.07
The chart of Calmar ratio for FTXH, currently valued at 0.57, compared to the broader market0.005.0010.0015.000.570.31
The chart of Martin ratio for FTXH, currently valued at 1.31, compared to the broader market0.0020.0040.0060.0080.00100.001.311.06
FTXH
XLV

The current FTXH Sharpe Ratio is 0.39, which is comparable to the XLV Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of FTXH and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
0.39
0.35
FTXH
XLV

Dividends

FTXH vs. XLV - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 2.13%, more than XLV's 1.22% yield.


TTM20232022202120202019201820172016201520142013
FTXH
First Trust Nasdaq Pharmaceuticals ETF
2.13%1.56%1.10%1.03%0.82%0.67%0.92%2.18%0.19%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.22%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

FTXH vs. XLV - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum XLV drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for FTXH and XLV. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-8.71%
-12.34%
FTXH
XLV

Volatility

FTXH vs. XLV - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 3.91% compared to Health Care Select Sector SPDR Fund (XLV) at 3.39%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%JulyAugustSeptemberOctoberNovemberDecember
3.91%
3.39%
FTXH
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab